What are the opening hours?

Monday 9am - 7pm Tuesday 9am - 7pm Wednesday 9am - 7pm Thursday 9am - 7pm Friday 9am - 7pm

SPER Market Research, #303, Tower B, KLJ Noida One, Noida (2026)

22/05/2026

𝐀𝐈, 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐚𝐩𝐩𝐫𝐨𝐚𝐜𝐡𝐞𝐬 𝐚𝐫𝐞 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐬𝐡𝐚𝐩𝐞 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐟𝐞𝐫𝐭𝐢𝐥𝐢𝐭𝐲 𝐜𝐚𝐫𝐞.

Our latest Fertility KOL Perception Study across the US & Europe explored how fertility specialists view emerging IVF innovations, fertility technology adoption, and unmet needs in reproductive healthcare.

𝐊𝐞𝐲 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 40 𝐟𝐞𝐫𝐭𝐢𝐥𝐢𝐭𝐲 𝐊𝐎𝐋𝐬:

• 30% identified AI-driven embryo selection as the top fertility innovation
• 77.5% are willing to adopt evidence-based fertility technologies
• Improving IVF success rates and affordability remain the biggest unmet needs
• AI-enabled fertility care and personalized treatment models are expected to drive future transformation

The study provides valuable insights for pharma, medtech, fertility clinics, and digital health stakeholders navigating the future of reproductive healthcare.

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐜𝐚𝐬𝐞 𝐬𝐭𝐮𝐝𝐲:
https://www.sperresearch.com/Case-Studies/fertility-kol-perception-study-us-eu

21/05/2026

𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐜𝐨𝐦𝐩𝐥𝐞𝐱𝐢𝐭𝐲 𝐢𝐬 𝐬𝐜𝐚𝐥𝐢𝐧𝐠 𝐟𝐚𝐬𝐭𝐞𝐫 𝐭𝐡𝐚𝐧 𝐞𝐯𝐞𝐫. 𝐁𝐮𝐭 𝐟𝐨𝐫 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐀𝐟𝐟𝐚𝐢𝐫𝐬 𝐭𝐞𝐚𝐦𝐬, 𝐭𝐡𝐞 𝐫𝐞𝐚𝐥 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞 𝐢𝐬𝐧’𝐭 𝐜𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐧𝐠 𝐦𝐨𝐫𝐞 𝐝𝐚𝐭𝐚 — 𝐢𝐭’𝐬 𝐭𝐮𝐫𝐧𝐢𝐧𝐠 𝐟𝐫𝐚𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐬𝐢𝐠𝐧𝐚𝐥𝐬 𝐢𝐧𝐭𝐨 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐜𝐥𝐚𝐫𝐢𝐭𝐲.

From tracking publication shifts across global markets to uncovering hidden co-authorship networks, success today depends on generating actionable insights in real time.

𝐓𝐡𝐞 𝐫𝐞𝐚𝐥 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧 𝐢𝐬:
How much time are your teams still losing on manual KOL profiling and fragmented research workflows?

At SPER Market Research, we’re moving beyond static databases.
With KOL Atlas, we’ve mapped 1M+ healthcare professionals globally using advanced AI-powered intelligence, semantic search, OpenSearch, and pgvector infrastructure—delivering a true 360° view of scientific influence.

𝐖𝐡𝐚𝐭 𝐭𝐡𝐢𝐬 𝐞𝐧𝐚𝐛𝐥𝐞𝐬 𝐟𝐨𝐫 𝐩𝐡𝐚𝐫𝐦𝐚 & 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐚𝐟𝐟𝐚𝐢𝐫𝐬 𝐭𝐞𝐚𝐦𝐬:
• 70% reduction in KOL research and profiling time
• Real-time monitoring with continuous daily & weekly intelligence updates
• Network visualizations to identify referral pathways, collaboration clusters, and competitive whitespace
• Faster, data-driven expert engagement decisions

Breakthrough therapies reach patients faster when insights move at the speed of innovation.

𝐑𝐞𝐚𝐝𝐲 𝐭𝐨 𝐦𝐨𝐝𝐞𝐫𝐧𝐢𝐳𝐞 𝐲𝐨𝐮𝐫 𝐊𝐎𝐋 𝐞𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐲?
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐝𝐞𝐦𝐨: https://www.sperresearch.com/KOL-Atlas

18/05/2026

𝐍𝐞𝐰 𝐂𝐚𝐬𝐞 𝐒𝐭𝐮𝐝𝐲 𝐏𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝: 𝐊𝐎𝐋 𝐏𝐞𝐫𝐜𝐞𝐩𝐭𝐢𝐨𝐧 𝐢𝐧 𝐔𝐥𝐜𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐂𝐨𝐥𝐢𝐭𝐢𝐬 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 (𝐔𝐒 & 𝐄𝐔)
How are gastroenterologists evaluating the evolving ulcerative colitis treatment landscape?

𝐎𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐩𝐫𝐢𝐦𝐚𝐫𝐲 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐬𝐭𝐮𝐝𝐲 𝐜𝐚𝐩𝐭𝐮𝐫𝐞𝐬 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 50 𝐊𝐎𝐋𝐬 𝐚𝐜𝐫𝐨𝐬𝐬 𝐭𝐡𝐞 𝐔𝐒 𝐚𝐧𝐝 𝐄𝐔5, 𝐞𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠:
• Biologic adoption trends in ulcerative colitis
• Physician perception of IL-23 inhibitors and JAK inhibitors
• Durable remission and unmet clinical needs
• Advanced UC therapy adoption barriers
• Future treatment expectations over the next 3–5 years
• Treatment sequencing and prescribing behavior trends

𝐊𝐞𝐲 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐬𝐭𝐮𝐝𝐲:
• 78% of KOLs most frequently prescribe anti-TNF biologics
• 74% identified durable remission as the top unmet need
• 42% expect IL-23 inhibitors to show the highest growth
• Safety concerns and lack of long-term data remain major adoption barriers

This study provides actionable market intelligence for pharma, biotech, medical affairs, competitive intelligence, and commercial strategy teams evaluating the future of inflammatory bowel disease therapies.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐜𝐚𝐬𝐞 𝐬𝐭𝐮𝐝𝐲 𝐡𝐞𝐫𝐞:
https://www.sperresearch.com/Case-Studies/ulcerative-colitis-treatment-kol-insights

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐎𝐮𝐫 𝐀𝐈-𝐏𝐨𝐰𝐞𝐫𝐞𝐝 𝐊𝐎𝐋 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦:
https://www.sperresearch.com/KOL-Atlas

15/05/2026

𝐀𝐈 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐢𝐬 𝐫𝐚𝐩𝐢𝐝𝐥𝐲 𝐦𝐨𝐯𝐢𝐧𝐠 𝐟𝐫𝐨𝐦 𝐞𝐱𝐩𝐞𝐫𝐢𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐭𝐨 𝐫𝐞𝐚𝐥-𝐰𝐨𝐫𝐥𝐝 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐰𝐨𝐫𝐤𝐟𝐥𝐨𝐰𝐬.

Our latest HCP perception study explores how US physicians and healthcare professionals are using OpenEvidence for:
• AI-powered clinical evidence retrieval
• literature summarization
• guideline review
• clinical decision support
• healthcare workflow optimization

𝐊𝐞𝐲 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 25 𝐇𝐂𝐏 𝐫𝐞𝐬𝐩𝐨𝐧𝐝𝐞𝐧𝐭𝐬:
• Citation-backed outputs significantly improve physician trust in AI tools
• Younger physicians and specialists show higher adoption frequency
• Most clinicians use AI as a supplemental support tool — not a replacement for physician judgment
• AI accuracy concerns and EMR integration remain major barriers to broader healthcare AI implementation
• Many respondents expect AI evidence platforms to become standard clinical support technologies within 3–5 years
𝐓𝐡𝐞 𝐬𝐭𝐮𝐝𝐲 𝐚𝐥𝐬𝐨 𝐡𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐛𝐫𝐨𝐚𝐝𝐞𝐫 𝐭𝐫𝐞𝐧𝐝𝐬 𝐬𝐡𝐚𝐩𝐢𝐧𝐠:
• healthcare AI adoption among physicians
• evidence-based medical AI tools
• clinical AI workflow efficiency
• physician perception of AI in healthcare
• AI medical literature summarization

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐜𝐚𝐬𝐞 𝐬𝐭𝐮𝐝𝐲 𝐡𝐞𝐫𝐞:
https://www.sperresearch.com/Case-Studies/openevidence-hcp-perception-study

What role do you think AI clinical decision support tools will play in everyday healthcare workflows over the next few years?

13/05/2026

𝐕𝐞𝐭𝐞𝐫𝐢𝐧𝐚𝐫𝐲 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐢𝐬 𝐧𝐨 𝐥𝐨𝐧𝐠𝐞𝐫 𝐚 𝐧𝐢𝐜𝐡𝐞 𝐬𝐞𝐫𝐯𝐢𝐜𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲

It is rapidly becoming a strategic global sector driven by AI, diagnostics, one health initiatives, pet humanization, and livestock innovation.

From companies like Zoetis and IDEXX to digital veterinary platforms and AI-powered diagnostics, the industry is evolving into a multi-billion-dollar ecosystem shaping the future of global health.

𝐊𝐞𝐲 𝐭𝐫𝐞𝐧𝐝𝐬 𝐜𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐛𝐥𝐨𝐠:
• Rise of companion animal healthcare
• AI and digital transformation in veterinary medicine
• Growth of veterinary diagnostics and preventive care
• One Health and zoonotic disease preparedness
• Private equity and consolidation in animal healthcare
• Emerging opportunities across Asia-Pacific, Latin America, and India

The blog also explores how veterinary healthcare companies are transitioning from traditional product businesses into integrated data-driven health platforms.

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐛𝐥𝐨𝐠 𝐡𝐞𝐫𝐞:
https://www.sperresearch.com/Blogs/veterinary-healthcare-strategic-global-industry

11/05/2026

𝐇𝐨𝐰 𝐢𝐧𝐟𝐥𝐮𝐞𝐧𝐭𝐢𝐚𝐥 𝐚𝐫𝐞 𝐊𝐞𝐲 𝐎𝐩𝐢𝐧𝐢𝐨𝐧 𝐋𝐞𝐚𝐝𝐞𝐫𝐬 (𝐊𝐎𝐋𝐬) 𝐢𝐧 𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐦𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐜 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬?
Our latest survey highlights how healthcare professionals perceive KOL impact across diabetes, obesity management, scientific communication, and physician education.

𝐊𝐞𝐲 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
• 52% consider KOLs extremely important in treatment approaches
• 48% say KOL opinions strongly influence prescribing behavior
• 60% find KOL-led scientific communication highly credible

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐜𝐚𝐬𝐞 𝐬𝐭𝐮𝐝𝐲 𝐡𝐞𝐫𝐞:
https://www.sperresearch.com/Case-Studies/kol-perception-metabolic-disease

10/05/2026

𝐀 𝐦𝐨𝐭𝐡𝐞𝐫’𝐬 𝐥𝐨𝐯𝐞 𝐢𝐬 𝐭𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐟𝐨𝐫𝐦 𝐨𝐟 𝐢𝐧𝐬𝐩𝐢𝐫𝐚𝐭𝐢𝐨𝐧 𝐰𝐞 𝐞𝐯𝐞𝐫 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞. 💖
Their strength teaches resilience, their guidance shapes confidence, and their sacrifices create opportunities for future generations.

This Mother’s Day, SPER Market Research honors all mothers who continue to inspire, nurture, and lead with endless dedication — both at home and in the professional world.

Thank you for being the foundation of countless success stories.
𝐖𝐢𝐬𝐡𝐢𝐧𝐠 𝐚𝐥𝐥 𝐭𝐡𝐞 𝐢𝐧𝐜𝐫𝐞𝐝𝐢𝐛𝐥𝐞 𝐦𝐨𝐭𝐡𝐞𝐫𝐬 𝐚 𝐯𝐞𝐫𝐲 𝐇𝐚𝐩𝐩𝐲 𝐌𝐨𝐭𝐡𝐞𝐫’𝐬 𝐃𝐚𝐲! 🌸

08/05/2026

𝐔.𝐒. 𝐊𝐎𝐋𝐬 𝐒𝐞𝐞 𝐒𝐭𝐫𝐨𝐧𝐠 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐏𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐢𝐧 𝐌𝐢𝐜𝐫𝐨𝐛𝐢𝐨𝐦𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬

Our latest KOL perception study explored how leading Gastroenterologists, Immunologists, Infectious Disease Specialists, and Pharma Researchers view the future of microbiome-based therapies in the U.S.

𝐊𝐞𝐲 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
• 80% of KOLs have moderate-to-high familiarity with microbiome therapies
• 88% see strong therapeutic potential across multiple indications
• C. difficile infection remains the leading validated use case
• IBD and oncology are emerging as high-growth opportunities
• Evidence gaps and regulatory ambiguity remain the biggest barriers
• 84% expect meaningful long-term clinical impact

The market is clearly shifting from experimental innovation to clinically credible therapy platforms.

As Phase III data strengthens and regulatory pathways mature, microbiome therapies could become one of the most transformative areas in next-generation medicine.

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐜𝐚𝐬𝐞 𝐬𝐭𝐮𝐝𝐲 𝐡𝐞𝐫𝐞:
https://www.sperresearch.com/Case-Studies/kol-perception-microbiome-therapy-us

04/05/2026

𝐈𝐬 𝐲𝐨𝐮𝐫 𝐊𝐎𝐋 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐲 𝐬𝐭𝐢𝐥𝐥 𝐬𝐭𝐮𝐜𝐤 𝐢𝐧 𝐬𝐩𝐫𝐞𝐚𝐝𝐬𝐡𝐞𝐞𝐭𝐬?
In pharma and medtech, KOL identification is no longer just a support function—it’s becoming a core strategic advantage.

𝐁𝐮𝐭 𝐡𝐞𝐫𝐞’𝐬 𝐭𝐡𝐞 𝐫𝐞𝐚𝐥 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧:
Are companies truly leveraging KOL mapping effectively?
In our latest US vs EU study, we found the following:
• 80% say KOL mapping is highly strategic
• Yet only 60% are satisfied with their current approach
• Data fragmentation and outdated insights remain the biggest challenges
• AI-driven KOL mapping is growing, but still underutilized

𝐒𝐨 𝐰𝐡𝐚𝐭’𝐬 𝐡𝐨𝐥𝐝𝐢𝐧𝐠 𝐭𝐞𝐚𝐦𝐬 𝐛𝐚𝐜𝐤?
Is it technology, data quality, or internal processes?
We would like to hear your perspective:
What’s the biggest challenge you face in KOL identification today?

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐜𝐚𝐬𝐞 𝐬𝐭𝐮𝐝𝐲:
https://www.sperresearch.com/Case-Studies/kol-mapping-pharma-us-eu

29/04/2026

Muscle preservation is emerging as a core priority in modern healthcare, extending beyond athletes and aging populations to areas like chronic disease management, surgical recovery, and weight-loss interventions.
With the rise of GLP-1 therapies, increasing aging demographics, and a growing focus on longevity, preserving lean muscle mass is becoming essential for improved health outcomes.

𝐈𝐧 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐛𝐥𝐨𝐠, 𝐰𝐞 𝐜𝐨𝐯𝐞𝐫:
• Key muscle preservation strategies in healthcare
• Impact of GLP-1 therapies on muscle mass
• Role of AI, wearables, and digital therapeutics
• Advances in pharmaceuticals and regenerative medicine
• Future technologies shaping muscle health management

As healthcare shifts toward preventive and personalized models, muscle health is becoming a foundational component of overall care.

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐛𝐥𝐨𝐠:
https://www.sperresearch.com/Blogs/muscle-preservation-in-healthcare-2026

27/04/2026

𝐀𝐈 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐢𝐬 𝐑𝐞𝐝𝐞𝐟𝐢𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞
Artificial intelligence is no longer just a support tool—it’s becoming a core driver of how healthcare organizations gather, analyze, and act on data.

Our latest case study highlights how AI is transforming market intelligence across the US and UK, based on real industry insights.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬:
• 64% of professionals see AI as a transformational force
• 80% report major impact on data aggregation and reporting
• Faster insights and predictive analytics are the biggest advantages
• Data privacy and transparency remain critical challenges
• Roles are shifting from data collection to strategic decision-making

As healthcare data continues to grow, AI is helping organizations move from reactive analysis to proactive strategy.

However, trust, compliance, and integration will define how far and how fast adoption scales.

𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐜𝐚𝐬𝐞 𝐬𝐭𝐮𝐝𝐲 𝐡𝐞𝐫𝐞:
https://www.sperresearch.com/Case-Studies/ai-in-healthcare-market-intelligence

SPER Market Research

22/05/2026

21/05/2026

18/05/2026

15/05/2026

13/05/2026

11/05/2026

10/05/2026

08/05/2026

04/05/2026

29/04/2026

27/04/2026

Address

Opening Hours

Telephone

Website

Alerts

Contact The Business

Shortcuts

Share

Category

Monday	9am - 7pm
Tuesday	9am - 7pm
Wednesday	9am - 7pm
Thursday	9am - 7pm
Friday	9am - 7pm